Xiao-Tong Lin
Overview
Explore the profile of Xiao-Tong Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Niu Y, Ai X, Lin X, Xu W, Lao S, Tian Z, et al.
Phytomedicine
. 2025 Mar;
140:156577.
PMID: 40023973
Background: Chronic infection with the hepatitis B virus (HBV) represents a significant global health concern. Baicalein, a naturally occurring flavone derived from the roots of Scutellaria baicalensis Georgi, has exhibited...
2.
Dai J, Lin X, Shen L, Zhang X, Ding Z, Wang J, et al.
World J Psychiatry
. 2025 Feb;
15(2):101818.
PMID: 39974492
Background: Depression is a significant psychiatric disorder with particularly high prevalence among adolescents. This mental health condition can have severe consequences, including academic failure, social withdrawal, and suicidal behavior. Given...
3.
Lin X, Zhou S, Sun Z, Cao M, Zhou T, Zhao L, et al.
Food Chem
. 2024 Nov;
464(Pt 2):141733.
PMID: 39503090
Hyperlipidemia poses a serious threat to human health, but its medication remains some issues including significant adverse reactions. Polyphenols exhibit great potential in lowering blood lipids and the lipid-lowering effects...
4.
Niu Y, Xia C, Ai X, Xu W, Lin X, Zhu Y, et al.
Acta Pharmacol Sin
. 2024 Oct;
46(3):653-661.
PMID: 39478159
Baicalin (BA), a natural component found in many traditional Chinese medicines, exerts protective effects against several viruses. Although our previous studies have revealed that the anti-hepatitis B virus (anti-HBV) activity...
5.
Lin X, Luo Y, Mao C, Gong Y, Hou Y, Zhang L, et al.
Hepatology
. 2024 Sep;
PMID: 39348425
Background And Aims: Patients with aggressive HCC have limited therapeutic options. Therefore, a better understanding of HCC pathogenesis is needed to improve treatment. Genomic studies of HCC have improved our...
6.
Li X, Zhang C, Lin X, Zhang J, Zhang Y, Yu H, et al.
Exp Mol Med
. 2024 Jan;
56(1):177-191.
PMID: 38177295
Dysregulation of wild-type p53 turnover is a key cause of hepatocellular carcinoma (HCC), yet its mechanism remains poorly understood. Here, we report that WD repeat and SOCS box containing protein...
7.
Xiong H, Yu H, Zhang J, Fang L, Wu D, Lin X, et al.
Mil Med Res
. 2023 Dec;
10(1):68.
PMID: 38124228
Background: Kirsten rat sarcoma (KRAS) and mutant KRAS have been implicated in human cancers, but it remains unclear whether their activation requires ubiquitination. This study aimed to investigate whether and...
8.
Zhang J, Lin X, Yu H, Fang L, Wu D, Luo Y, et al.
Exp Mol Med
. 2023 Oct;
55(10):2281-2286.
PMID: 37783772
No abstract available.
9.
Zhang J, Lin X, Yu H, Fang L, Wu D, Luo Y, et al.
Exp Mol Med
. 2023 Aug;
55(10):2162-2176.
PMID: 37653031
Metastatic hepatocellular carcinoma (HCC) is the most lethal malignancy and lacks effective treatment. FBXL6 is overexpressed in human hepatocellular carcinoma (HCC), but whether this change drives liver tumorigenesis and lung...
10.
Lin X, Zhang J, Liu Z, Wu D, Fang L, Li C, et al.
Cell Rep
. 2023 Jul;
42(7):112812.
PMID: 37450367
Hepatocellular carcinoma (HCC), the most common liver cancer, occurs mainly in men, but the underlying mechanism remains to be further explored. Here, we report that ubiquitinated glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is...